| 000 | 01393 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515050629.0 | ||
| 264 | 0 | _c20070207 | |
| 008 | 200702s 0 0 jpn d | ||
| 022 | _a0031-6903 | ||
| 024 | 7 |
_a10.1248/yakushi.126.1309 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamataki, Tetsuya | |
| 245 | 0 | 0 |
_a[How I was enticed into molecular toxicology]. _h[electronic resource] |
| 260 |
_bYakugaku zasshi : Journal of the Pharmaceutical Society of Japan _cDec 2006 |
||
| 300 |
_a1309-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2A6 |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xetiology |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Biology |
| 650 | 0 | 4 |
_aNitrosamines _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 |
_aThiazolidines _xpharmacokinetics |
| 650 | 0 | 4 | _aToxicology |
| 773 | 0 |
_tYakugaku zasshi : Journal of the Pharmaceutical Society of Japan _gvol. 126 _gno. 12 _gp. 1309-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/yakushi.126.1309 _zAvailable from publisher's website |
| 999 |
_c16709286 _d16709286 |
||